Navigation Links
BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
Date:9/24/2013

JERUSALEM, Sept. 24, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a Phase 1/2 trial for BL-7010 - for the treatment of celiac disease - with the Finnish National Supervisory Authority for Welfare and Health (Valvira). The relevant ethics committee has already approved commencement of the study.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769 )

The Phase 1/2 study is a two-part (single and repeated), double-blind, placebo-controlled, dose escalation study of BL-7010 in 32 patients at a world-leading site for celiac disease research in Finland. The primary objective of the study is to assess the safety of single and repeated ascending doses of BL-7010 in well-controlled celiac patients. Secondary objectives include an assessment of the systematic exposure, if any, of BL-7010 in the study patients. The CRO and data management vendors have already been selected for the study, which is expected to start in the fourth quarter of this year.

"We look forward to commencing the Phase 1/2 clinical study for BL-7010 by the end of the year. The study will be conducted in Finland, which has a significantly higher prevalence of celiac disease than other countries and is a world leader in celiac research," stated Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx. "We are very enthusiastic about this unique product, which is generating a lot of excitement from both the scientific and medical communities. Despite the unmet medical need and the huge size of the celiac market, there is no available treatment for the disease apart from a lifelong gluten-free d
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
2. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
3. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
4. BioLineRx to Present at 15th International Celiac Disease Symposium
5. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
6. BioLineRx Appoints B. J. Bormann to Board of Directors
7. BioLineRx Reports Second Quarter 2013 Results
8. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
9. Positron Announces Reverse Stock Split and Registration as a Delaware Corporation
10. GenVec Announces Dismissal Of Class Action Lawsuit
11. Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015   InspireMD, Inc. (NYSE MKT: ... protection systems ("EPS"), today announced that its CGuard TM ... principle investigator Prof. Piotr Musialek , at the ... Paris, France . PARADIGM, an investigator-initiated ... c A roti D revascularization I n symptomatic ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
(Date:5/21/2015)...  When Ryan Rendino first felt the ... neck, he figured it was a muscle ... from weight lifting. But the ... A series of doctor appointments followed ... Michel Kliot, MD , a Northwestern ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... , DENVER, Oct. 27 A Denver ophthalmologist recently became ... lens during cataract surgery, raising the bar for patient care ... his patients. , Dr. Paul Cutarelli, director of Cutarelli Vision ... nanoFLEX lens in October in the eye of a 70-year-old ...
... 27 Astellas Pharma Inc. ("Astellas") and Medivation, Inc. ... entered into a global agreement to develop and commercialize ... cancer. MDV3100 is currently being evaluated in the ... prostate cancer who were previously treated with docetaxel-based chemotherapy. ...
Cached Medicine Technology:Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 3Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 2Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 3Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 4Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 5Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer 6
(Date:5/23/2015)... York, NY (PRWEB) May 23, 2015 ... announced that, “the company has been the target ... as a part of the company’s ongoing Information Technology ... on health insurers.” , The most notable attack ... year when Anthem Inc., the nation’s second largest health ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood company ... with reclaimed wood, introducing their latest reclaimed wood products ... newest offerings, Vat 35, Reclaimed Teak , and ... America's largest design event. , “Designers, architects, builders, and ... to see and feel the variety of wood surfaces ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Hundreds ... on behalf of individuals who allegedly experienced serious ... use continue to move forward in the U.S. ... a Pretrial Order dated May 4, 2015, the ... documents and electronically stored information. Among other things, ...
(Date:5/22/2015)... 22, 2015 Hands On HealthCare Massage ... 2015, the Annual One Day Sale on Massage ... On HCMT offers drastically reduced certificates one day a year. ... enough sessions, through what used to be the slowest time ... the community as well. This once a year occurrence has ...
Breaking Medicine News(10 mins):Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3
... ... ... ... ...
... Research on ocular cancer has expanded in recent years ... the advancement of knowledge in the field, according to ... of Ophthalmology , one of the JAMA/Archives journals. ... writes author J. William Harbour, M.D., of Washington University ...
... RIDGE, Tenn., March 8, 2010 -- A technology that ... on a material surface has earned the Department of ... Transfer Project of the Year Award from the Southeast ... The regional organization is part of a nationwide ...
... of growing arteries could lead to a "biological bypass"or a ... Medicine researchers report with their colleagues in the April issue ... arteries can become blocked with plaque, leading to a decrease ... Over time this blockage can lead to debilitating chest pain ...
... ... based Une Belle Vie Memorial Urns offers unique, artisan made, decorative urns ... A wide selection of biodegradable urns are also available. The company focuses ... the future or coping with the passing of a loved one. For ...
... treatment in low-risk patients, study finds , MONDAY, March ... glaucoma successfully if they catch it early, but a ... treating those at risk of developing the disease. , ... with higher-than-normal pressure in the eye won,t need to ...
Cached Medicine News:Health News:Soft? Firm? When Choosing a Mattress, One Firmness Does Not Fit All 2Health News:Soft? Firm? When Choosing a Mattress, One Firmness Does Not Fit All 3Health News:Soft? Firm? When Choosing a Mattress, One Firmness Does Not Fit All 4Health News:ORNL earns project of year award from tech transfer group 2Health News:Personal Tragedy Reveals Untapped Artistic Expression / Family Business Memorializes Loved Ones with Compassion During Grieving 2Health News:Waiting Safe for Some at Risk of Glaucoma 2
Uses a rocking action to stir the plasma. Frozen plasma floats back and forth inside the plasma bag to speed thawing....
Conventional Digitally-Controlled Water Baths...
Conventional Digitally-Controlled Water Baths...
... Biliary Stent, a flexible, self-expanding nitinol design ... in the biliary system, is now available ... U.S. Food and Drug Administration. Incorporating the ... Zilver stents successful around the world, the ...
Medicine Products: